- ISIN
- US87918A1051
- CUSIP
- 87918A105
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Jul 1, 2015
Highlights
- Market Cap
- $1.36B
- Enterprise Value
- $1.63B
- EPS (TTM)
- -$0.97
- Total Revenue (TTM)
- $2.51B
- Gross Profit (TTM)
- $1.74B
- EBITDA (TTM)
- -$43.17M
- Year Range
- $4.40 - $9.77
- Target Price
- $7.58
- ROA (TTM)
- -6.10%
- ROE (TTM)
- -12.81%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TDOC Performance Chart
Teladoc Health, Inc. (TDOC) is up 8.3% since the beginning of the year. At $8 per share, TDOC is trading 22.4% below its 52-week high of $10. Investors who bought $1,000 worth of TDOC shares 5 years ago would now be looking at an investment worth $47.
Loading charts...
Returns By Period
Teladoc Health, Inc. (TDOC) has returned 8.29% so far this year and 9.86% over the past 12 months. Over the last ten years, TDOC has returned -5.31% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Teladoc Health, Inc.
- 1D
- -6.07%
- 1M
- 15.37%
- YTD
- 8.29%
- 6M
- 4.41%
- 1Y
- 9.86%
- 3Y*
- -31.65%
- 5Y*
- -45.70%
- 10Y*
- -5.31%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
TDOC Monthly Returns History
Based on dividend-adjusted daily data since Jul 1, 2015, TDOC's average daily return is +0.03%, while the average monthly return is +0.23%. At this rate, an investment would double in approximately 25.1 years.
Historically, 50% of months were positive and 50% were negative. The best month was Jun 2016 with a return of +40.2%, while the worst month was Apr 2022 at -53.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, TDOC closed higher 50% of trading days. The best single day was Jul 26, 2023 with a return of +27.0%, while the worst single day was Apr 28, 2022 at -40.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -22.14% | -3.49% | 3.61% | 11.19% | 25.58% | -0.39% | 8.29% | ||||||
| 2025 | 11.77% | -5.91% | -16.74% | -9.67% | -3.76% | 25.87% | -17.22% | 7.21% | 0.00% | 11.64% | -12.05% | -7.77% | -22.99% |
| 2024 | -9.84% | -22.39% | 0.13% | -15.56% | -11.84% | -12.99% | -3.58% | -23.97% | 28.03% | -1.96% | 33.11% | -24.12% | -57.82% |
| 2023 | 24.31% | -9.90% | -2.23% | 2.43% | -12.74% | 9.37% | 17.58% | -23.95% | -17.89% | -11.03% | 9.67% | 18.80% | -8.88% |
| 2022 | -16.46% | -1.04% | -4.98% | -53.20% | 0.98% | -2.58% | 10.96% | -15.71% | -18.38% | 16.92% | -3.81% | -17.05% | -74.24% |
| 2021 | 31.94% | -16.20% | -17.79% | -5.17% | -12.63% | 10.43% | -10.73% | -2.71% | -12.19% | 17.96% | -32.31% | -9.31% | -54.08% |
Benchmark Metrics
Teladoc Health, Inc. has an annualized alpha of -9.11%, beta of 1.19, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since July 01, 2015.
- This stock participated in 182.12% of S&P 500 Index downside but only 89.51% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -9.11%
- Beta
- 1.19
- R²
- 0.12
- Upside Capture
- 89.51%
- Downside Capture
- 182.12%
Return for Risk
Risk / Return Rank
TDOC ranks 47 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Teladoc Health, Inc. (TDOC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TDOC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.86 | ||
| Sortino ratioReturn per unit of downside risk | -2.03 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.37 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 0.19 | 2.78 | -2.60 |
| Martin ratioReturn relative to average drawdown | 0.35 | 12.44 | -12.09 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Teladoc Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Teladoc Health, Inc. was 98.48%, occurring on Feb 12, 2026. The portfolio has not yet recovered.
The current Teladoc Health, Inc. drawdown is 97.43%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -98.48%Feb 2026 | 5y 4d | — | 5y 4moFeb 2021 - now |
2016 bear market2016 | -72.72%Mar 2016 | 7mo 26d | 1y 2mo | 1y 10moAug 2015 - Jun 2017 |
Rate-hike selloffLate 2018 | -50.34%Dec 2018 | 2mo 24d | 1y 13d | 1y 3moOct 2018 - Jan 2020 |
2020 bear market2020 | -30.86%Nov 2020 | 3mo 7d | 2mo 13d | 5mo 20dAug 2020 - Jan 2021 |
2017 bear market2017 | -24.19%Nov 2017 | 2mo 1d | 15d | 2mo 16dSep 2017 - Nov 2017 |
Drawdown Indicators
| TDOC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.48% | -56.78% | -41.70% |
Max Drawdown (1Y)Largest decline over 1 year | -52.75% | -9.10% | -43.65% |
Max Drawdown (3Y)Largest decline over 3 years | -84.98% | -18.90% | -66.08% |
Max Drawdown (5Y)Largest decline over 5 years | -97.39% | -25.43% | -71.96% |
Max Drawdown (10Y)Largest decline over 10 years | -98.48% | -33.92% | -64.56% |
Current DrawdownCurrent decline from peak | -97.43% | -1.80% | -95.63% |
Average DrawdownAverage peak-to-trough decline | -54.32% | -10.71% | -43.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.01% | 2.03% | +25.98% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Teladoc Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Teladoc Health, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TDOC relative to other companies in the Health Information Services industry. Currently, TDOC has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TDOC in comparison with other companies in the Health Information Services industry. Currently, TDOC has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TDOC
Add Teladoc Health, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TDOC